Reviewed,
UniProtKB/Swiss-Prot Q9NR71 (ASAH2_HUMAN)
Last modified
July 7, 2009.
Version 51.
History...
Clusters with 100%,
90%,
50% identity |
Documents (5) |
Third-party data |
Customize display | text xml rdf/xml gff fasta |
Names and origin
| Protein names | Recommended name: Neutral ceramidase Short name=N-CDase Short name=NCDase EC=3.5.1.23 Alternative name(s): Acylsphingosine deacylase 2 N-acylsphingosine amidohydrolase 2 Non-lysosomal ceramidase BCDase LCDase Short name=hCD Cleaved into the following chain: 1- Recommended name: Neutral ceramidase soluble form | ||||
| Gene names |
| ||||
| Organism | Homo sapiens (Human) [Complete proteome] | ||||
| Taxonomic identifier | 9606 [NCBI] | ||||
| Taxonomic lineage | Eukaryota › Metazoa › Chordata › Craniata › Vertebrata › Euteleostomi › Mammalia › Eutheria › Euarchontoglires › Primates › Haplorrhini › Catarrhini › Hominidae › Homo |
Protein attributes
| Sequence length | 780 AA. |
| Sequence status | Complete. |
| Sequence processing | The displayed sequence is further processed into a mature form. |
| Protein existence | Evidence at protein level. |
General annotation (Comments)
| Function | Hydrolyzes the sphingolipid ceramide into sphingosine and free fatty acid at an optimal pH of 6.5-8.5. Acts as a key regulator of sphingolipid signaling metabolites by generating sphingosine at the cell surface. Acts as a repressor of apoptosis both by reducing C16-ceramide, thereby preventing ceramide-induced apoptosis, and generating sphingosine, a precursor of the antiapoptotic factor sphingosine 1-phosphate. Probably involved in the digestion of dietary sphingolipids in intestine by acting as a key enzyme for the catabolism of dietary sphingolipids and regulating the levels of bioactive sphingolipid metabolites in the intestinal tract. Ref.2 Ref.7 |
| Catalytic activity | N-acylsphingosine + H2O = a carboxylate + sphingosine. Ref.4 Ref.8 |
| Enzyme regulation | Inhibited by dithiothreitol (DTT), 2-mercaptoethanol, Zn2+, Cu2+ and Fe2+. Enhanced by Na+ and Ca2+, and at lower level Mg2+ and Mn2+. |
| Subcellular location | Cell membrane; Single-pass type II membrane protein. Note: The neutral ceramidase soluble form is a secreted protein. Ref.4 Ref.6 |
| Tissue specificity | Primarily expressed in the intestine (Ref.9). Ubiquitously expressed with higher levels in kidney, skeletal muscle and heart (Ref.4). According to Ref.9, ubiquitous expression attributed to ASAH2 may be actually that of the paralog ASAH2B. Ref.4 Ref.9 |
| Post-translational modification | N-glycosylated. Required for enzyme activity By similarity. O-glycosylated. Required to retain it as a type II membrane protein at the cell surface. Ref.6 Phosphorylated. May prevent Ubiquitination and subsequent degradation By similarity. Ubiquitinated, leading to its degradation by the proteasome. Ubiquitination is triggered by nitric oxid By similarity. |
| Sequence similarities | Belongs to the neutral ceramidase family. |
| Caution | According to some authors (Ref.4) it is mitochondrial. However, they used a shorter form in its N-terminus, which may explain this localization which probably does not exist in vivo. |
| Biophysicochemical properties | Kinetic parameters: KM=71.4 µM for octanoyl-sphingosine KM=66 µM for palmitoyl-sphingosine KM=60.1 µM for D-erythro-C12-NBD-ceramide Vmax=160 µmol/min/mg enzyme with octanoyl-sphingosine as substrate Vmax=16 µmol/min/mg enzyme with palmitoyl-sphingosine as substrate Vmax=0.68 nmol/min/mg enzyme with D-erythro-C12-NBD-ceramide as substrate pH dependence: Optimum pH is 7.5-9.5. |
Ontologies
| Keywords | |
|---|---|
| Biological process | Apoptosis Lipid metabolism Sphingolipid metabolism |
| Cellular component | Cell membrane Membrane |
| Coding sequence diversity | Alternative splicing Polymorphism |
| Domain | Signal-anchor Transmembrane |
| Molecular function | Hydrolase |
| PTM | Glycoprotein Phosphoprotein Ubl conjugation |
| Technical term | Complete proteome |
| Gene Ontology (GO) | |
| Biological process | apoptosis Inferred from electronic annotation. Source: UniProtKB-KW ceramide metabolic process Ref.4Traceable author statement. Source: ProtInc signal transduction Ref.4Traceable author statement. Source: ProtInc |
| Cellular component | integral to membrane Inferred from electronic annotation. Source: UniProtKB-KW mitochondrion Ref.4Traceable author statement. Source: ProtInc plasma membraneInferred from electronic annotation. Source: UniProtKB-SubCell |
| Molecular function | ceramidase activity Inferred from electronic annotation. Source: EC |
| Complete GO annotation... | |
Alternative products
| This entry describes 2 isoforms produced by alternative splicing. [Align] [Select] | ||||||
| Isoform 1 (identifier: Q9NR71-1) This isoform has been chosen as the 'canonical' sequence. All positional information in this entry refers to it. This is also the sequence that appears in the downloadable versions of the entry. | ||||||
| Isoform 2 (identifier: Q9NR71-2) The sequence of this isoform differs from the canonical sequence as follows: 410-444: Missing. | ||||||
| Note: No experimental confirmation available. |
Sequence annotation (Features)
| Feature key | Position(s) | Length | Description | Graphical view | Feature identifier | ||||
Molecule processing | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Chain | 1 – 780 | 780 | Neutral ceramidase | PRO_0000247099 | |||||
| Chain | 99 – 780 | 682 | Neutral ceramidase soluble form By similarity | PRO_0000247100 | |||||
Regions | |||||||||
| Topological domain | 1 – 12 | 12 | Cytoplasmic Potential | ||||||
| Transmembrane | 13 – 33 | 21 | Signal-anchor for type II membrane protein Potential | ||||||
| Topological domain | 34 – 780 | 747 | Lumenal Potential | ||||||
| Region | 770 – 780 | 11 | Required for correct folding and localization By similarity | ||||||
Sites | |||||||||
| Active site | 354 | 1 | Nucleophile Ref.8 | ||||||
Amino acid modifications | |||||||||
| Glycosylation | 62 | 1 | O-linked (GalNAc...) Potential | ||||||
| Glycosylation | 67 | 1 | O-linked (GalNAc...) Potential | ||||||
| Glycosylation | 68 | 1 | O-linked (GalNAc...) Potential | ||||||
| Glycosylation | 70 | 1 | O-linked (GalNAc...) Potential | ||||||
| Glycosylation | 73 | 1 | O-linked (GalNAc...) Potential | ||||||
| Glycosylation | 74 | 1 | O-linked (GalNAc...) Potential | ||||||
| Glycosylation | 76 | 1 | O-linked (GalNAc...) Potential | ||||||
| Glycosylation | 78 | 1 | O-linked (GalNAc...) Potential | ||||||
| Glycosylation | 79 | 1 | O-linked (GalNAc...) Potential | ||||||
| Glycosylation | 80 | 1 | O-linked (GalNAc...) Potential | ||||||
| Glycosylation | 82 | 1 | O-linked (GalNAc...) Potential | ||||||
| Glycosylation | 84 | 1 | O-linked (GalNAc...) Potential | ||||||
| Glycosylation | 98 | 1 | N-linked (GlcNAc...) Potential | ||||||
| Glycosylation | 151 | 1 | N-linked (GlcNAc...) Potential | ||||||
| Glycosylation | 217 | 1 | N-linked (GlcNAc...) Potential | ||||||
| Glycosylation | 468 | 1 | N-linked (GlcNAc...) Potential | ||||||
| Glycosylation | 564 | 1 | N-linked (GlcNAc...) Potential | ||||||
| Glycosylation | 730 | 1 | N-linked (GlcNAc...) Potential | ||||||
| Glycosylation | 779 | 1 | O-linked (GalNAc...) Potential | ||||||
Natural variations | |||||||||
| Alternative sequence | 410 – 444 | 35 | Missing in isoform 2. | VSP_019928 | |||||
| Natural variant | 51 | 1 | T → A: dbSNP rs7067625. | VAR_027064 | |||||
| Natural variant | 346 | 1 | A → S: dbSNP rs993869. | VAR_027065 | |||||
Experimental info | |||||||||
| Mutagenesis | 258 | 1 | S → A: Impairs enzyme activity. Ref.8 | ||||||
| Mutagenesis | 352 | 1 | D → A: Abolishes enzyme activity. Ref.8 | ||||||
| Mutagenesis | 354 | 1 | S → A: Abolishes enzyme activity. Ref.8 | ||||||
| Mutagenesis | 362 | 1 | C → A: Abolishes enzyme activity. Ref.8 | ||||||
| Mutagenesis | 374 | 1 | S → A: Impairs enzyme activity. Ref.8 | ||||||
| Mutagenesis | 396 | 1 | S → A: No effect. Ref.8 | ||||||
| Mutagenesis | 595 | 1 | S → A: Impairs enzyme activity. Ref.8 | ||||||
| Mutagenesis | 729 | 1 | S → A: Impairs enzyme activity. Ref.8 | ||||||
| Sequence conflict | 274 | 1 | S → P in AAL06061. Ref.1 | ||||||
| Sequence conflict | 274 | 1 | S → P in AAF86240. Ref.4 | ||||||
| Sequence conflict | 602 | 1 | T → A in AAL06061. Ref.1 | ||||||
| Sequence conflict | 602 | 1 | T → A in AAF86240. Ref.4 | ||||||
| Sequence conflict | 689 | 1 | T → N in CAI17190. Ref.3 | ||||||
Sequences
| ||||||||||||||||||||||||
References
| « Hide 'large scale' references | |
| [1] | "Neutral ceramidase gene: role in regulating ceramide-induced apoptosis." Choi M.S., Anderson M.A., Zhang Z., Zimonjic D.B., Popescu N., Mukherjee A.B. Gene 315:113-122(2003) [PubMed: 14557071] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [GENOMIC DNA]. |
| [2] | "Roles for C16-ceramide and sphingosine 1-phosphate in regulating hepatocyte apoptosis in response to tumor necrosis factor-alpha." Osawa Y., Uchinami H., Bielawski J., Schwabe R.F., Hannun Y.A., Brenner D.A. J. Biol. Chem. 280:27879-27887(2005) [PubMed: 15946935] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), FUNCTION. |
| [3] | "The DNA sequence and comparative analysis of human chromosome 10." Deloukas P., Earthrowl M.E., Grafham D.V., Rubenfield M., French L., Steward C.A., Sims S.K., Jones M.C., Searle S., Scott C., Howe K., Hunt S.E., Andrews T.D., Gilbert J.G.R., Swarbreck D., Ashurst J.L., Taylor A., Battles J. Rogers J.Nature 429:375-381(2004) [PubMed: 15164054] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA]. |
| [4] | "Molecular cloning and characterization of a human mitochondrial ceramidase." El Bawab S., Roddy P., Qian T., Bielawska A., Lemasters J.J., Hannun Y.A. J. Biol. Chem. 275:21508-21513(2000) [PubMed: 10781606] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [MRNA] OF 20-780 (ISOFORM 1), ENZYME ACTIVITY, BIOPHYSICOCHEMICAL PROPERTIES, POSSIBLE SUBCELLULAR LOCATION, TISSUE SPECIFICITY. |
| [5] | "The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC)." The MGC Project Team Genome Res. 14:2121-2127(2004) [PubMed: 15489334] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] OF 20-780 (ISOFORM 2). |
| [6] | "Subcellular localization of human neutral ceramidase expressed in HEK293 cells." Hwang Y.H., Tani M., Nakagawa T., Okino N., Ito M. Biochem. Biophys. Res. Commun. 331:37-42(2005) [PubMed: 15845354] [Abstract] Cited for: SUBCELLULAR LOCATION, GLYCOSYLATION. |
| [7] | "Mechanisms of sphingosine and sphingosine 1-phosphate generation in human platelets." Tani M., Sano T., Ito M., Igarashi Y. J. Lipid Res. 46:2458-2467(2005) [PubMed: 16061940] [Abstract] Cited for: FUNCTION. |
| [8] | "Identification of a novel amidase motif in neutral ceramidase." Galadari S., Wu B.X., Mao C., Roddy P., El Bawab S., Hannun Y.A. Biochem. J. 393:687-695(2006) [PubMed: 16229686] [Abstract] Cited for: ENZYME ACTIVITY, BIOPHYSICOCHEMICAL PROPERTIES, ACTIVE SITE, MUTAGENESIS OF SER-258; ASP-352; SER-354; CYS-362; SER-374; SER-396; SER-595 AND SER-729. |
| [9] | "A novel gene derived from a segmental duplication shows perturbed expression in Alzheimer's disease." Avramopoulos D., Wang R., Valle D., Fallin M.D., Bassett S.S. Neurogenetics 8:111-120(2007) [PubMed: 17334805] [Abstract] Cited for: TISSUE SPECIFICITY. |
| + | Additional computationally mapped references. |
Cross-references
Sequence databases | |
|---|---|
| AY049008 Genomic DNA. Translation: AAL06061.1. Different initiation. AF449759 mRNA. Translation: AAQ04667.2. AL450382 Genomic DNA. Translation: CAI15870.1. Different initiation. AL589794 Genomic DNA. Translation: CAI15766.1. Sequence problems. AL589794 Genomic DNA. Translation: CAI15767.1. Sequence problems. AL954360 Genomic DNA. Translation: CAI17190.1. AF250847 mRNA. Translation: AAF86240.1. BC107105 mRNA. Translation: AAI07106.1. | |
| IPI | IPI00419967. IPI00645992. |
| RefSeq | NP_001137446.1. NP_063946.2. |
| UniGene | Hs.512645 Hs.537110 Hs.710005 |
3D structure databases | |
| ModBase | Search... |
PTM databases | |
| PhosphoSite | Q9NR71. |
Proteomic databases | |
| PRIDE | Q9NR71. |
Genome annotation databases | |
| Ensembl | ENSG00000188611. Homo sapiens. [Contig view] |
| GeneID | 56624. |
| KEGG | hsa:56624. |
| UCSC | uc001jjd.1. human. uc009xos.1. human. |
Organism-specific databases | |
| GeneCards | GC10M051617. |
| H-InvDB | HIX0058802. |
| HGNC | HGNC:18860. ASAH2. |
| MIM | 611202. gene. |
| PharmGKB | PA38720. |
| GenAtlas | Search... |
Phylogenomic databases | |
| HOVERGEN | Q9NR71. |
| OMA | Q9NR71. SWFAVHP. |
Enzyme and pathway databases | |
| BRENDA | 3.5.1.23. 247. |
Gene expression databases | |
| Bgee | Q9NR71. |
| CleanEx | HS_ASAH2. |
| GermOnline | ENSG00000188611. Homo sapiens. |
Family and domain databases | |
| InterPro | IPR006823. Ceramidase_alk. [Graphical view] |
| PANTHER | PTHR12670. Ceramidase_alk. 1 hit. |
| Pfam | PF04734. Ceramidase_alk. 1 hit. [Graphical view] |
| ProtoNet | Search... |
Other Resources | |
| NextBio | 62071. |
| SOURCE | Search... |
Entry information
| Entry name | ASAH2_HUMAN | ||||||||
| Accession | Primary (citable) accession number: Q9NR71 Secondary accession number(s): Q3KNU1 Q71ME6 | ||||||||
| Entry history |
| ||||||||
| Entry status | Reviewed (UniProtKB/Swiss-Prot) | ||||||||
| Annotation project | HPI (Human Proteome Initiative) | ||||||||
Relevant documents
| Human chromosome 10 Human chromosome 10: entries, gene names and cross-references to MIM |
| Human entries with polymorphisms or disease mutations List of human entries with polymorphisms or disease mutations |
| Human polymorphisms and disease mutations Index of human polymorphisms and disease mutations |
| MIM cross-references Online Mendelian Inheritance in Man (MIM) cross-references in UniProtKB/Swiss-Prot |
| SIMILARITY comments Index of protein domains and families |

Clusters with


